Latest Research Report on Glycomics/Glycobiology
Market begins with an extensive
presentation and then investigates broad into specific segments such as raw
material, application, end user, and region, policy study, value chain
structure, and upcoming trends in particular segments or regions. The report on
Glycomics/Glycobiology prepare a case for investments in different regions
based on a practical view of their regulatory outline, manufacturing dynamics,
and availability of skills and resources in that region.
The global
Glycomics/Glycobiology Market is expected to grow at a CAGR of 14.4% in the
forthcoming period. Glycomics is a wide and emerging scientific field
emphasizing on defining functional aspects of glycans in biological systems.
The higher the complexity of glycome, which is defined as the range of glycans
particularly in a cell or organism leads to multiple challenges that could be
subjectively decoded.
The challenges are resolved
with progress in mass spectrometry along with expansion of genetic and cell
biology studies. On the contrary, determining a specific glycan and glycan-binding
proteins by incorporating new technology of glycan microarrays guide the glycan
function.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/glycomics-glycobiology-market/request-sample
Glycomics/glycobiology
industry is driven by factors such as growing investments for R&D with a
strong emphasis of pharmaceutical and biotechnology companies on innovative
product development. Rise in development of new vaccines for genetic diseases
comprising diabetes and influenza will add to the market growth in the forecast
period. Rise in government funding for R&D activities and novel approach
for drug production process are the other factors driving the market.
Product segmentation for
glycomics market includes enzymes, reagents, kits and instruments. Enzymes are
further quad furcated into glycosyltransferases, neuraminidases, sialyl
transferases and glycosidases. Enzyme segment accounts for a high market share
due to wide applications for various drug recovery procedures. Application
segment for glycomics/glycobiology industry includes drug discovery
&development diagnostics.
Regional segmentation for
glycomics/glycobiology market includes North America, Latin America, Europe,
Asia-Pacific, Middle East and Africa. North America dominates the market due to
high revenue share and presence of large pharmaceutical & biotechnology
firms. Presence of developed healthcare infrastructure and availability of
advanced products in these regions is likely to promote the market growth.
Asia-Pacific’s glycobiology
industry is estimated to grow at a higher CAGR in the forecast period due to
booming healthcare infrastructure in emerging economies. Availability of large
pool of patients and low cost of clinical trials and accessibility of skilled
personnel have propelled the market growth in Asia-Pacific’s market. The key
players in the glycomics/glycobiology market include Thermo Fisher Scientific
Inc, Agilent Technologies, Bruker, Merck KGaA, Shimazdu Corp, New England
Biolabs, Waters Corporation, and Takara Bio Inc.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment